TUCSON, Ariz., Aug. 10, 2020 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the signing of a Commercialization and Distribution Agreement (Master Agreement) with QIAGEN Manchester Limited, a wholly owned subsidiary of QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) (QIAGEN).Continue reading
Author Archive: AZBio
FDA Approves Genentech’s Evrysdi (risdiplam) for Treatment of Spinal Muscular Atrophy (SMA) in Adults and Children 2 Months and Older
In two clinical trials, Evrysdi improved motor function in people living with SMA over a broad spectrum of ages and levels of disease severity, including Types 1, 2, and 3 SMA
- Evrysdi helped infants survive without permanent ventilation and achieve the ability to sit without support, a key motor milestone not normally seen in the natural course of the disease
- Evrysdi is the first and only medicine for SMA that can be taken at home
UArizona Announces On Ramp to In-Person Classes Beginning Aug. 24
Labs and art studios will be among the first courses to take place in person, while other classes will begin online on Aug. 24.
Continue reading
University of Arizona Awarded $26M to Architect the Quantum Internet
The University of Arizona will lead a new National Science Foundation Engineering Research Center, called the Center for Quantum Networks, with core partners Harvard, MIT and Yale.
Ensuring Scientific Justice by Building Bridges to Minority Communities is Centerpiece of BIOEquality Agenda
The BIOEquality Agenda is a national effort in collaboration with our partners and member organizations in the biotechnology sector that aims to counteract the systemic inequality, injustice, and unfair treatment of underserved communities. Continue reading
Researchers to Develop Device to Accurately and Quickly Detect COVID-19
The Center for Applied NanoBioscience and Medicine Awarded Grant from NASA to Develop Prototype by September 2020
Amid the coronavirus pandemic, a team of researchers at the University of Arizona College of Medicine – Phoenix are developing a device that will easily and accurately detect COVID-19 in a matter of minutes.Continue reading
Johnson & Johnson Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine
Company working to ensure broad global access to COVID-19 vaccine candidate, following approval from regulatorsContinue reading
Woodbury named CEO of Science Foundation Arizona
ASU’s chief science and technology officer will lead the nonprofit, which connects researchers, businessesContinue reading
AdvaMed’s National Testing Registry: Shipments of COVID-19 Molecular Diagnostic Tests Reach 100 Million
AdvaMed’s National Testing Registry: Shipments of COVID-19 Molecular Diagnostic Tests Reach 100 MillionContinue reading
Undaunted: ASU Science forges ahead, despite worldwide crisis
The global pandemic caused by the novel coronavirus has affected nearly every aspect of daily life in Arizona and across the nation, putting many summer activities on pause in the midst of great uncertainly. But as ASU advances an ambitious agenda designed to keep the Sun Devil community safe this coming academic year, research at the Biodesign Institute marches forward.Continue reading